PubMed=7653891; DOI=10.2460/ajvr.1995.56.06.801
Deborah W. Knapp, Thomas C.-K. Chan, Thomas Kuczek, William J. Reagan, Beth Park;
Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells.
Am. J. Vet. Res. 56:801-805(1995)

PubMed=18562222; DOI=10.1016/j.urolonc.2008.02.015
Deepika Dhawan, Jose A. Ramos-Vara, Jane C. Stewart, Rong Zheng, Deborah W. Knapp;
Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Urol. Oncol. 27:284-292(2009)

PubMed=26401343; DOI=10.1186/s40575-015-0028-3; PMCID=PMC4579363
Susan G. Shapiro, Deborah W. Knapp, Matthew Breen;
A cultured approach to canine urothelial carcinoma: molecular characterization of five cell lines.
Canine Genet. Epidemiol. 2:15.1-15.14(2015)

PubMed=27257868; DOI=10.1371/journal.pone.0156689; PMCID=PMC4892608
Junko Maeda, Coral Eva Froning, Colleen A. Brents, Barbara J. Rose, Douglas H. Thamm, Takamitsu A. Kato;
Intrinsic radiosensitivity and cellular characterization of 27 canine cancer cell lines.
PLoS ONE 11:e0156689.1-e0156689.18(2016)

PubMed=27197945; DOI=10.1111/vco.12192; PMCID=PMC5656225
Jared S. Fowles, Deanna D. Dailey, Daniel L. Gustafson, Douglas H. Thamm, Dawn L. Duval;
The Flint Animal Cancer Center (FACC) canine tumour cell line panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.
Vet. Comp. Oncol. 15:481-492(2017)

PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350
Tahlita C.M. Zuiverloon, Florus Christiaan de Jong, James C. Costello, Dan Theodorescu;
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)